Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage.
A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.

Market Analysis and Insights: Global Cancer Diagnostics Device Market
The global Cancer Diagnostics Device market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Cancer Diagnostics Device Scope and Segment
Cancer Diagnostics Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Diagnostics Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cancer Diagnostics Device market is segmented into
Companion Diagnostics
Molecular Diagnostics

Segment by Application, the Cancer Diagnostics Device market is segmented into
Lung
Breast
Colorectal
Prostate
Cervical
Others

Regional and Country-level Analysis
The Cancer Diagnostics Device market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Diagnostics Device market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape

and Cancer Diagnostics Device Market Share Analysis

Cancer Diagnostics Device market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Cancer Diagnostics Device by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Cancer Diagnostics Device business, the date to enter into the Cancer Diagnostics Device market, Cancer Diagnostics Device product introduction, recent developments, etc.
The major vendors covered:
Abbott Diagnostics
Agilent Technologies
BD
bioMérieux
Qiagen
Roche Diagnostics
...